Pharmaceuticals

World Active Pharmaceutical Ingredient (API) Market - Opportunities and Forecasts, 2014 - 2020

  • ALL349697
  • 0 Pages
  • October 2015
  • Pharmaceuticals

Increase in Abbreviated New Drug Applications (ANDA) over the past years has fostered the demand for API market. Furthermore, Indian companies making increased entries related to Drug Master File (DMF) indicates APIs market gaining traction. Stringent regulatory policies in the European Union is likely to restrain market growth. Patent expiry of biological drugs creates new growth opportunities for key API manufacturers.

The report segments the market on the basis of synthesis, type of manufacturer, type and therapy. Based on synthesis, this market is segmented into synthetic API and biotech API. The former is further segmented into Innovative synthetic APIS and generic synthetic APIS, while the latter is further segmented on the basis of products and type. The biotech APIS market, by product is further segmented into monoclonal antibodies, recombinant proteins and vaccines. On the basis of type of manufacturer, this market is segmented into captive API manufacturers, merchant API manufacturers, innovative APIS and generic APIS. On the basis of type, the market is segmented into innovative APIS segment and generic APIS segment. On the basis of therapy, the market is segmented into oncology, diabetes, cardiovascular disease, Cns and neurological disorders, orthopedic disorders, nephrology, ophthalmology, pulmonology, gastrointestinal disorders and endocrinology.

On the basis of geography, the market is segmented into North America, Europe, Asia-Pacific, and Latin America, Middle East & Africa (LAMEA).

Key market players in this market are Teva Pharmaceutical Industries Limited, Dr. Reddys Laboratories Ltd., Sun Pharmaceutical Industries Ltd., Aurobindo Pharma Ltd., Novartis International AG, Albemarle Corporation, Sigma-Aldrich Corporation, Mylan Inc., and Allergan PLC

KEY BENEFITS FOR STAKEHOLDERS:

  • The report provides a comprehensive analysis of current & future market trends, key market challenges and emerging avenues for the growth of this market globally.
  • The report offers latest technological innovations and the recent R&D developments.
  • The report offers an insight into competitive landscape in terms of new technological developments, untapped segments, and value chain analysis.
  • This report entails the detailed quantitative analysis of the current market and estimations through 2014 and 2020, which assists in identifying the prevailing market opportunities.
  • The report offers detailed segmentation and analyzes the key segments in terms of market size by value and volume and country-level analysis to provide an in-depth understanding of the market.
  • Porters Five Forces analysis is offered in the report along with highlighting bargaining power of buyers and suppliers.
  • The report offers strategic analysis of financial status of key market players, and highlights market share of key vendors.
  • The report offers information on the status of new projects along with offering investment feasibility analysis of the same.

KEY SEGMENATATION

  • By Synthesis
    • Synthetic Active Pharmaceutical Ingredient
      • Innovative Synthetic APIS
      • Generic Synthetic APIS
  • By Product
    • Monoclonal Antibodies
    • Recombinant Proteins
    • Vaccines
  • By Type
    • Innovative Biotech APIS
    • Biogenerics/Biosimilars
  • By Type of Manufacturer
    • Captive API Manufacturers
    • Merchant API Manufacturers
      • Innovative APIS
      • Generic APIS
  • By Type
    • Innovative APIS Segment
    • Generic APIS Segment
  • By Therapy
    • Oncology
    • Diabetes
    • Cardiovascular Disease
    • Cns and Neurological Disorders
    • Orthopedic Disorders
    • Nephrology
    • Ophthalmology
    • Pulmonology
    • Gastrointestinal Disorders
    • Endocrinology
  • By Geography
    • North America
    • Europe
    • Asia-Pacific
    • LAMEA
  • Key Company Profile
    • Teva Pharmaceutical Industries Limited
    • Dr. Reddys Laboratories Ltd.
    • Sun Pharmaceutical Industries Ltd.
    • Aurobindo Pharma Ltd.
    • Novartis International AG
    • Albemarle Corporation
    • Sigma-Aldrich Corporation
    • Mylan Inc.
    • Allergan PLC.
Please Select Format

Enquiry About Report

Need More Information

Contact us
+ 1-800-910-6452
+1-971-202-1575
+91 20 66346066
--- or ---
help@bigmarketresearch.com

 

UPCOMING MARKET RESEARCH REPORTS

Global General Medicine Education Publishing Market (Type, Geography) Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Opportunities, Segmentation, Forecast (2013-2020)

General medicine is a branch of medicine that deals with diagnosis and treatment of diseases associated with internal organs. It is also called as Internal Medicine. General medicine education market has shown substantial growth due to the adoption of internal medicine as a career option by medical students.

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

Cancer Vaccine Market Global Scenario, Market Size, Outlook, Trend and Forecast, 2015- 2024

Cancer vaccines are biological response modifiers. These vaccines work by stimulating or restoring the immune system�s ability to fight against infections and diseases. It is used either as stand-alone therapies ...

July 2017  |   Price:$ 4995    | Pre Book Price:$ 4995

Read More >>

Anterior Uveitis Asia-Pacific Market Research Report, 2014 - 2020

Anterior uveitis is an eye inflammation that involves middle layer of the eye specifically, iris (colored part of the eye) and ciliary body (adjacent tissue). Untreated anterior uveitis results in ...

July 2017  |   Price:$ 2850    | Pre Book Price:$ 2850

Read More >>

Nanomedicine Asia-Pacific Market Research Report, 2014 - 2020

Nanomedicine is the applied branch of nanotechnology. Application of nanomedicines ranges from nonmaterial to nanoelectronic and in the near future, it could possibly expand to molecular nanotechnology. Biological, pharmaceutical and ...

July 2017  |   Price:$ 2850    | Pre Book Price:$ 2850

Read More >>

Autoimmune Disorders Treatment Asia-Pacific Market Research Report, 2014 - 2020

Graves disease, Multiple sclerosis, Myasthenia gravis, Rheumatoid arthritis, Pernicious anemia and Systemic lupus erythematosus are the most prevalent types of autoimmune disorders. The prevalence of autoimmune diseases is high in ...

July 2017  |   Price:$ 2850    | Pre Book Price:$ 2850

Read More >>

Dilated Cardiomyopathy Asia-Pacific Market Research Report, 2014 - 2020

Dilated cardiomyopathy (DCM) results from heart enlargement. It is a fetal cardiac disorder, where heart walls become weak and heart fails to pump blood efficiently. It could have negative impact ...

July 2017  |   Price:$ 2850    | Pre Book Price:$ 2850

Read More >>

2017 © Copyright Big Market Research

View Pricing >>